M*Modal is a healthcare technology provider, offering cloud-based, artificial intelligence-powered systems that aim to improve capture of patient data. 3M’s Health Information Systems business works with 8,000-plus healthcare organizations worldwide. Its offerings include clinical documentation and risk assessment systems.
Per the agreement, 3M will maintain a strategic business relationship with M*Modal’s remaining transcription, scribing and coding services business, which it is not acquiring.
M*Modal’s technology business’ annual revenue is expected to total approximately $200 million. Around 750 M*Modal employees will join 3M once the transaction is completed. 3M estimates the acquisition to be $0.10 dilutive to earnings in the first 12 months following completion of the transaction on a GAAP reported basis.
The transaction, which is subject to closing conditions and regulatory approval, is expected to close in the first half of 2019.
More articles on health IT:
Teladoc faces class action lawsuit: 8 things to know
Google plans $1B New York City expansion
Vermont community hospital notifies 32,000 after data breach: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
